Clinithink
PrivateLast Round
Growth Equity
May 8, 2023
Est. Valuation
$50M
Total Funding Raised
$10M
Company Overview
Clinithink is a healthcare technology company that provides an AI-powered platform to transform unstructured clinical narrative from medical records into structured, actionable data for healthcare and life sciences organizations.
Sector
Healthcare & Life Sciences
Verticals
NLP & Conversational AI, Clinical Trials, Healthcare Analytics, Revenue Cycle
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clinithink Comparables
Compare Clinithink with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Savana | 87% | |
| emtelligent | 85% | |
| LynxCare | 85% |
Clinithink Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | May 8, 2023 | ||||
| Series D | Jan 7, 2019 | ||||
| Series C | Jul 1, 2017 | ||||
| VC Round | Jun 30, 2014 | ||||
| Series A | Jul 29, 2012 |
Clinithink Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Merck Global Health Innovation Fund | Growth Equity |
| Vanguard Atlantic | Series D, Series A, Series C, VC Round |
| Truehelm | Series D, Growth Equity |
| Development Bank of Wales | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Monthly visitors increased 53% MoM.
- May 1, 2025
Monthly visitors increased 61% MoM.
Clinithink Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Clinithink's valuation, stock price, and market status.
Is Clinithink a public or private company?
Clinithink is a private company.
What is the current stock price of Clinithink?
Clinithink is a private company with no public stock price. Caplight tracks Clinithink's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Clinithink worth (valuation)?
Clinithink's valuation is estimated at $50.0M based on funding round data.
Can I buy Clinithink stock?
Clinithink shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Clinithink's last funding round?
Clinithink's most recent funding round was Growth Equity on January 7, 2019.
Who are the main investors in Clinithink?
Key investors in Clinithink include Merck Global Health Innovation Fund, Vanguard Atlantic, Truehelm.
Will Clinithink IPO soon?
No public IPO plans have been announced for Clinithink.
How can I track Clinithink secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Clinithink's secondary market activity and sign up for updates.